The replication of human immunodeficiency retroviruses involves a comp
lex series of events that is regulated at both transcriptional and pos
ttranscriptional levels. The tat gene product is a potent trans-activa
tor of viral transcription and therefore an attractive target for the
development of antiviral drugs. Tat-defective HIV-1 proviral DNA clone
s have been shown previously to be replication defective. In this stud
y, we report that tat-defective HIV-1 and HIV-2 viral DNA transfected
into U937 cells can direct efficient viral replication in the presence
of transcriptional stimulators such as TNF-alpha and PMA. In MT-4 cel
ls, tat-defective HIV-1 can replicate without any stimulation. The vir
uses recovered from MT-4 cells remained tat defective defined by their
inability to infect T cell lines (e.g., Molt 4/8) although replicatio
n could be rescued with cytokines. Limited replication was observed in
primary mononuclear cells. Furthermore, we showed that Ro 24-7429, a
potent tat antagonist and antiviral compound, failed to suppress HIV-1
replication in TNF-alpha-stimulated T cells. These results have impor
tant implications for targeting tat as a therapeutic strategy for AIDS
.